Arthritis Research & Therapy

official impact factor 4.36

Open Access

Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden

Lars E Kristensen*, Tore Saxne, Jan-Åke Nilsson and Pierre Geborek

Arthritis Research & Therapy 2006, 8:R174 doi:10.1186/ar2084

Accesses  

  • Last 30 days: 73 accesses
  • Last 365 days: 677 accesses
  • All time: 5560 accesses

Cited by